Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Transition Therapeutics Inc    TTH   CA8937162094

TRANSITION THERAPEUTICS INC (TTH)
Mes dernières consult.
Most popular
  Report  
 SummaryChartsNewsCompany 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
08/22/2016 08/23/2016 08/25/2016 08/26/2016 08/29/2016 Date
2.06 2.02 2.02 1.92 1.93 Last
400 700 500 180 7200 Volume
+0.98% -1.94% 0.00% -4.95% +0.52% Change
Company
Transition Therapeutics, Inc. develops novel therapeutics for disease indications.It operates through research and development of therapeutic agents segment.The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome.Its metabolic drug candidate... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on TRANSITION THERAPEUTICS IN
2016TRANSITION THERAPEUTICS : Announces Special Shareholder Meeting Voting Results I..
PR
2016TRANSITION THERAPEUTICS : Receives Notification From NASDAQ
PR
2016TRANSITION THERAPEUTICS : Announces Third Quarter Fiscal 2016 Financial Results
PR
2016TRANSITION THERAPEUTICS TO HOLD CONF : 30 p.m. est
PR
2016TRANSITION THERAPEUTICS : Provides Update on Type 2 Diabetes Drug Candidate TT40..
PR
2016TRANSITION THERAPEUTICS : Receives Notification From NASDAQ
PR
2016TRANSITION THERAPEUTICS : to Present at the 36th Annual Cowen Healthcare Confere..
PR
2016TRANSITION THERAPEUTICS : Announces Second Quarter Fiscal 2016 Financial Results
PR
2016TRANSITION THERAPEUTICS : to Hold Conference Call on Second Quarter Fiscal 2016 ..
PR
2016TRANSITION THERAPEUTICS : Announces Top Line Phase 2 Clinical Study Results of D..
PR
More news
Sector news : Biopharmaceuticals
04/26Bayer to Sell Further Crop Science Businesses to BASF for Up to EUR1.7 Billio..
DJ
04/26Bayer sells more assets, bringing Monsanto deal closer
RE
04/26Bayer sells more crop science assets to BASF for 1.7 billion euros
RE
04/26Overshadowed by Takeda bid, Shire reports solid start to year
RE
04/26ABBVIE : Humira Helps AbbVie -- Earnings Review
DJ
More sector news : Biopharmaceuticals
News from SeekingAlpha
2016Transition Therapeutics shareholders back OPKO merger 
2016OPKO buys Transition Therapeutics in all-stock deal 
2016Bayer expands development program for prostate cancer candidate BAY-1841788 w.. 
2016Transition Therapeutics' (TTHI) CEO Chip Brewer on Q3 2016 Results - Earnings.. 
2016Transition Therapeutics reports FQ3 results 
Chart TRANSITION THERAPEUTICS IN
Duration : Period :
Transition Therapeutics In Technical Analysis Chart | TTH | CA8937162094 | 4-Traders
Managers
NameTitle
Antonio F. Cruz Chairman & Chief Executive Officer
Carl Damiani President & Chief Operating Officer
Aleksandra Pastrak VP-Clinical Development & Medical Officer
Michael Richard Dwyer Ashton Director
Paul Baehr Director
Sector and Competitors
1st jan.Capitalization (M$)
TRANSITION THERAPEUTICS INC0.00%0
CSL LIMITED14.47%55 635
BIOGEN-15.42%55 461
ALEXION PHARMACEUTICALS-10.94%23 683
GRIFOLS-6.86%17 270
BIOMARIN PHARMACEUTICAL-9.02%14 285